• Focus Asset Management cut its CMG Pharmaceutical stake to 1,033,057 shares, or 0.69%, from 7,518,796 shares, or 5.14%.
• The change was triggered by an early redemption (put option) on convertible bonds, prompting a more than 1% ownership shift.
• The disclosure cited Oct. 12, 2026 as the triggering date, based on a report dated Oct. 14, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CMG Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261014000124), on October 14, 2026, and is solely responsible for the information contained therein.